# VentriNova

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ventrinova

- Industry: Biotechnology
- Headquarters: New York, US
- Total disclosed funding: $1M
- Latest round: Seed (Sep 3, 2009)
- Investors on record: 1

## About

Founded in 2006 and based in New York, US, VentriNova Inc. operates as a biotechnology company that develops regenerative medicines for patients with heart diseases. The firm's products include VN-100, a vector-based gene therapy that causes cardiomyocyte division in adult heart tissue by delivery of the cyclin A2 gene.

## Funding rounds

- Seed, Sep 3, 2009, $1M — Broadview Ventures

## Investors

- Broadview Ventures (https://capitalatlas.ai/funds/broadview-ventures) — Seed